Nottingham, United Kingdom

Martin Whitaker

This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignee: Diurnal Limited. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Whitaker. Retrieved from https://idiyas.com/inventor/martin-whitaker-72uxnhki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Martin Whitaker

Introduction

Martin Whitaker is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of 5 patents to his name, Whitaker's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents is a formulation for hydrocortisone that allows for controlled release. This innovative pharmaceutical formulation is designed to treat conditions that would benefit from a delayed release of hydrocortisone. Such conditions include adrenal insufficiency, inflammatory disorders, and depression. The implications of this work are profound, as it offers new avenues for managing these health issues effectively.

Career Highlights

Whitaker is currently associated with Diurnal Limited, a company focused on developing innovative treatments for chronic endocrine diseases. His expertise in pharmaceutical formulations has been instrumental in advancing the company's mission to improve patient outcomes.

Collaborations

Throughout his career, Martin Whitaker has collaborated with several talented individuals, including Hiep Huatan and Richard Ross. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Martin Whitaker's contributions to pharmaceutical innovations, particularly in controlled release formulations, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments that can greatly benefit patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…